Srinivas Narayanan, the CTO of OpenAI's B2B Applications, has announced his decision to resign from the company next week.

AI analysis of Reddit posts uncovered potential side effects of GLP-1 drugs that may be underreported, demonstrating the value of social media in early drug safety insights.

LeTourneau University staff and students gathered in Longview on Friday to break ground on their new Christian Polytechnic ...

OpenAI executive Srinivas Narayanan, an IIT Madras alumnus who helped scale ChatGPT and API products, has announced his exit ...

Engineers at Northwestern University have taken a striking leap toward merging machines with the human brain by printing ...

Scientists looking for the causes of neurodegenerative diseases like Parkinson's and Alzheimer's generally focus on the ...

Explore 25 advanced ancient technologies that modern science still cannot fully explain. From pyramids to precision stonework ...